Company Profile

Inhibikase Therapeutics, Inc. is a pharmaceutical company focused on the development of protein kinase inhibitors for treatment of neurological infections and neurodegenerative diseases. The Company’s pipeline includes multiple product candidates developed from its proprietary RAMP drug innovation and prodrug technology engines, using the same clinically validated kinase target. The Company is headquartered in Atlanta with additional offices in Boston, Massachusetts.

Contact Information

Milton H. Werner, PhD
Georgia Office
3350 Riverwood Parkway
Suite 1900
Atlanta, GA 30339
Phone: 678-392-3419
info@inhibikase.com

Massachusetts Office
One Marina Park Drive
Suite 1410
Boston, MA 02210
Phone: 617-936-0184
info@inhibikase.com